Vitamin D deficiency and allergies found to exacerbate severe conjunctivitis, reveals new studyA study by the Tear Science Lab at Narayana Nethralaya, Bengaluru, has discovered a connection between low vitamin D levels and severe conj...
COVID-19 infection can change structure of our genes: StudyThe genetic materials in our cells are stored in a structure called chromatin. Some viruses of other categories have been reported to hijac...
Here's why sepsis can be so deadly, and so expensive to heal fromThe medical condition is known to claim lives of 50 million people globally.
Indian-American doctor identifies possible COVID-19 treatmentThe researchers detailed how the inflammatory cell death signaling pathway worked, which led to potential therapies to disrupt the process.
Steroid treatment should be reserved for sickest COVID-19 patients, say scientistsScientists, including those from St. Jude Children's Research Hospital in the US, assessed the levels of the immune system protein cytokine...
High levels of just one type of molecule seen in COVID-19 patients prevents immunityScientists, including those from Harvard University in the US, noted that the release of massive amounts of molecules involved in cell-cell...
Some patients suffering from severe conditions may not develop immunity to coronavirusHigh levels of a molecule in Covid patients may prevent them from developing immunity.
We are going to do phase-4 trial of psoriasis drug on Covid patients: Kiran Mazumdar ShawThe Drug Controller gave Biocon an restricted emergency use authorisation to try out and continue to treat Covid-19 patients and then do a ...
Biocon gets DCGI nod to use Itolizumab in moderate to severe Covid-19 patientsBiocon said the approval is based on the results from the successful conclusion of a randomized, controlled clinical trial at multiple hosp...
Scientists discover small proteins which may reduce inflammation caused by COVID-19The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring sma...
Blood test can help suggest which Covid-19 patient needs a ventilator, determine the role of diabetesThe researchers tested blood samples taken from the patients within 48 hours of diagnosis.
Biosimilar drugs can help us reach $1 billion target soon: Christiane Hamacher, CEO, Biocon BiologicsIt is all about reaching our $1billion revenue target by FY22 and to reach 5 million patients by end of 2022, says Christiane Hamacher.
Biocon gets DCGI nod for device to treat critical COVID-19 patientsThe company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-infl...
How COVID-19 can damage your heartSimply put, when a person is infected by the novel coronavirus his or her immune system tries to fight back. Too many cytokines — small pro...
Biocon says use of Itolizumab in COVID-19 treatment encouragingBiocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pha...
Treating Covid-19: Clinical trials using arthritis drug get nod“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biol...
Yoga practitioners at less risk of inflammatory diseases: StudyInflammation is body's response to an injury and involves secretion of pro-inflammatory cytokines in the blood.